To identify specific signatures as potential therapeutic targets for TRAIL-resistant phenotype in human cancer, we analyzed the gene expression profile in TRIAIL-sensitive cancer cells verse resistant cancer cells. This evidence concerns the gene TNFSF10 and cancer.